Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiers

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Virology|August 21, 2015
Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A VirusesJudith Verhelst, Jan Spitaels, Cindy Nürnberger, et al.
Journal of Virology|January 11, 2013
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in miceSarah De Baets, Bert Schepens, Koen Sedeyn, et al.
Vaccine|September 20, 2005
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionMarina De Filette, Anna Ramne, Ashley Birkett, et al.
Virology|May 26, 2005
Universal influenza A vaccine: optimization of M2-based constructsMarina De Filette, Willy Min Jou, Ashley Birkett, et al.
Vaccine|October 7, 2008
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodiesMarina De Filette, Wouter Martens, Anouk Smet, et al.
Vaccine|October 21, 2009
M2e-based universal influenza A vaccineWalter Fiers, Marina De Filette, Karim El Bakkouri, et al.
The Journal of General Virology|October 23, 2010
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotectiveMarina De Filette, Tine Ysenbaert, Kenny Roose, et al.
The Journal of Biological Chemistry|February 7, 2008
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2Marina De Filette, Wouter Martens, Kenny Roose, et al.
Vaccine|February 5, 2008
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccineDubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, et al.
Vaccine|July 4, 2006
Improved design and intranasal delivery of an M2e-based human influenza A vaccineMarina De Filette, Walter Fiers, Wouter Martens, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Virology|August 21, 2015
Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A VirusesJudith Verhelst, Jan Spitaels, Cindy Nürnberger, et al.
Journal of Virology|January 11, 2013
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in miceSarah De Baets, Bert Schepens, Koen Sedeyn, et al.
Vaccine|September 20, 2005
The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protectionMarina De Filette, Anna Ramne, Ashley Birkett, et al.
Virology|May 26, 2005
Universal influenza A vaccine: optimization of M2-based constructsMarina De Filette, Willy Min Jou, Ashley Birkett, et al.
Vaccine|October 7, 2008
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodiesMarina De Filette, Wouter Martens, Anouk Smet, et al.
Vaccine|October 21, 2009
M2e-based universal influenza A vaccineWalter Fiers, Marina De Filette, Karim El Bakkouri, et al.
The Journal of General Virology|October 23, 2010
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotectiveMarina De Filette, Tine Ysenbaert, Kenny Roose, et al.
The Journal of Biological Chemistry|February 7, 2008
An influenza A vaccine based on tetrameric ectodomain of matrix protein 2Marina De Filette, Wouter Martens, Kenny Roose, et al.
Vaccine|February 5, 2008
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccineDubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, et al.
Vaccine|July 4, 2006
Improved design and intranasal delivery of an M2e-based human influenza A vaccineMarina De Filette, Walter Fiers, Wouter Martens, et al.
Pageof 4